retatrutide and blood sugar New GLP-3 drug significantly slashes both weight levels in Phase III trial How Retatrutide works: mechanism of
Description
As of January 2026, Retatrutide has not yet received FDA approval and is not available for prescription use
doi: 10.1007/s11606-024-09076-z [DOI] [PMC free article] [PubMed] [Google Scholar] 20.Franklin JM, Rassen JA, Ackermann D, Bartels DB, Schneeweiss S
Metabolic adaptation is most likely the reason for this plateau [11] rather than poor response or resistance to the medication
& Rai, T
Gastrointestinal side effects , such as nausea, vomiting, and reduced appetite, are common with Ozempic and may lead to dehydration or electrolyte imbalances
E., Miller, A
